research use only
Cat.No.S8608
|
In vitro |
DMSO
: 19 mg/mL
(71.63 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 265.23 | Formula | C10H11N5O4 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 34240-05-6 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | C1=NC(=C2C(=N1)N(C=N2)C(C=O)OC(CO)C=O)N | ||
| Targets/IC50/Ki |
AdoHcy hydrolase
(Cell-free) 40 nM
|
|---|---|
| In vitro |
Adenosine dialdehyde (AdOx), an indirect inhibitor that can be incorporated by cells, inhibits S-adenosyl-L-homocystein hydrolase, resulting in the accumulation of S-adenosyl-L-homo cystein (Adoicy), a product inhibitor of methyltransferases that utilize S-adenosyl-L-methionine (AdoMet) as the methyl group donor. This compound inhibited the Tax-activated NF-κB pathway, resulting in reactivation of p53 and induction of p53 target genes. Analysis of the NF-κB pathway demonstrated that AdOx treatment resulted in degradation of the IκB kinase complex and inhibition of NF-κB through stabilization of the NF-κB inhibitor IκBα. It induced G2/M cell cycle arrest and cell death in HTLV-1-transformed but not control lymphocytes.
|
| In vivo |
AdOx (Adenosine Dialdehyde) exerts a potent inhibitory effect on the in situ growth of established murine neuroblastoma (MNB) tumors, prolongs the life span of tumor bearing mice, and does not suppress hematopoiesis when administered by steady state infusion. It inhibits the replication of L1210 leukemia cells and increased life span approximately 40% when administered i.p. at a dose of 20 mg/kg/day until death.
|
References |
|
| Methods | Biomarkers | Images | PMID |
|---|---|---|---|
| Western blot | p-Tau / Tau AUF1 |
|
23943618 |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.